Table 2 The relationships between inflammation-related markers (the 9 combinations and 2 scoring systems) and survival.

From: Combination of lymphocyte count and albumin concentration as a new prognostic biomarker for rectal cancer

Variables OS RFS
5-year OS (%) P value 5-year RFS (%) P value
NLR
> 2.3 87.4   71.2  
≤ 2.3 87.4 0.165 74.0 0.293
PLR
> 140 84.9   66.6  
≤ 140 89.6 0.069 78.9 0.088
PAR
> 56,300 89.9   74.6  
≤ 56,300 85.1 0.847 70.8 0.900
LMR
> 4.53 87.2   73.8  
≤ 4.53 87.7 0.462 71.2 0.517
MAR
> 85.2 91.6   79.2  
≤ 85.2 83.6 0.572 66.5 0.111
NP
> 767,000 (× 103) 89.7   77.3  
≤ 767,000  (× 103) 85.2 0.841 68.0 0.311
LA
> 5950 91.1   80.4  
≤ 5950 83.1 0.007* 63.8 0.015*
NM
> 1,210,000 90.1   78.5  
≤ 1,210,000 84.7 0.610 66.5 0.212
MP
> 76,600 (× 103) 91.2   78.0  
≤ 76,600 (x 10(× 103) 84.1 0.254 67.9 0.281
GPS
0 86.5   71.7  
1 100.0   83.3  
2 100.0 0.526 88.8 0.494
SIS
0 89.1   79.2  
1 84.9   67.6  
2 91.1 0.499 74.3 0.226
  1. NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio, PAR platelet-to-albumin ratio, LMR lymphocyte-to-monocyte ratio, MAR monocyte-to-albumin ratio, NP neutrophil × platelet, LA lymphocyte × albumin, NM neutrophil × monocyte, MP monocyte × platelet, GPS Glasgow prognostic scale, SIS systemic inflammation scale.
  2. * P < 0.05.